ARTICLE | Company News
Weizmann Institute of Science, TxCell deal
July 18, 2016 7:00 AM UTC
TxCell exercised an option under a 2015 deal for exclusive, worldwide rights to a chimeric antigen receptor (CAR) regulatory T cells patent from the Yeda Research and Development Co. Ltd. technology t...